Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study Vicente Pallarés-Carratalá; Antonio Ruiz-García; Adalberto Serrano-Cumplido; Antonio Segura Fragoso; Verónica Fernández-Pascual; Beatriz Sánchez-Sánchez; María Inmaculada Cervera-Pérez; Francisco Javier Alonso-Moreno; Ezequiel Arranz-Martínez; Alfonso Barquilla-García; Daniel Rey-Aldana; José Polo García; Sergio Cinza-Sanjurjo;

Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB study Antonio Ruiz-García; Ezequiel Arranz-Martínez; Luis Enrique Morales-Cobos; Juan Carlos García-Álvarez; Nerea Iturmendi-Martínez; Montserrat Rivera-Teijido;

The impact of metabolic syndrome on coronary artery severity in patients with acute myocardial infarction: A perspective from a developing country Hai Phuong Nguyen Tran; Tai Nhat Nguyen; Kha Minh Nguyen; Sang Quang Ly; Sy Van Hoang;